Base Year
Historical Year
Forecast Year
The global proton therapy market size was valued at USD 1314.6 million in 2023, driven by the increasing incidence of cancer across the globe. The market is expected to grow at a CAGR of 12.4% during the forecast period of 2024-2032, with the values likely to rise from USD 1477 million in 2024 to USD 3749.8 million by 2032.
Proton therapy is a type of radiation therapy that treats cancer with the help of positively charged ions (protons). It may also be used in the treatment of some noncancerous tumours or in conjunction with treatments like chemotherapy or surgery. Proton therapy has garnered high popularity owing to its minimal side effects when compared to conventional methods as doctors have better hold at controlling the site of energy accumulation.
The rising prevalence of cancer is a major factor leading to proton therapy market demand. While radiation has been a common part of cancer treatment, proton therapy is now gaining popularity owing to its minimal side effects when compared to traditional radiotherapy. It also facilitates the patients to continue with day-to-day lives owing to its painless nature.
The proton therapy market value is also anticipated to grow with increasing encouragement by regulatory authorities like American Society for Radiation Oncology (ASTRO) to apply the therapy on patients. Consequently, new age pharmaceutical companies are now dedicated to use the therapy. In September 2023, Shuttle Pharmaceuticals Holdings, Inc. conveyed their commitment to employ the treatment on patients at the Hampton University Proton Therapy Institute Prostate Cancer & Men's Health Fair.
The market is anticipated to grow with the rising set up proton system into the existing infrastructure. In October 2023, Hitachi launched Southeast Asia’s first proton therapy system in National Cancer Centre Singapore (NCCS). This system is equipped with four rotating gantries and a Real-time image Gating system for Proton Therapy (RGPT) to treat tumours in motion due to respiration. It is also enabled with advanced spot scanning technology to precisely irradiate tumors with compound shapes.
Market Breakup by Product Type
Market Breakup by Components
Market Breakup by Type
Market Breakup by Set-Up Systems
Market Breakup by Applications
Market Breakup by End User
Market Breakup by Region
The United States alone is expected to record around 1,958,310 new cancer cases in 2023, hence, it is anticipated to hold a major part of the global proton therapy market share in upcoming years. Having a well-structured infrastructure that can easily adopt newer technologies is another essential component of the large market size. The region is experiencing validation from numerous upcoming companies which are willingly adapting to the latest techniques and devising better means of application.
Having several academic and healthcare institutions at home, Europe holds a massive market share as well. With the help of numerous awareness and educational campaigns, there is emphasis on educating the healthcare staff with the technical knowledge of using all the latest technologies.
The Asia Pacific region, on the other hand, is projected to encounter an upswing in the proton therapy market growth in the foreseeable future. With high national and foreign investments, emerging markets like India are continuously improving their research and healthcare infrastructure. Major healthcare companies are also investing in the Asian markets to leverage the easy availability of resources present in the region.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Components |
|
| Breakup by Type |
|
| Breakup by Set-Up Systems |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 1314.6 million in 2023 driven by the growing incidence of cancer across the globe.
The market is anticipated to grow at a CAGR of 12.4% during the forecast period of 2024-2032, likely to reach a market value of USD 3749.8 million by 2032.
The market demand is driven by the emphasis on finding better treatment alternatives that offer minimal side effects.
The current market trend is the increased set up of proton therapy systems in hospitals. In October 2023, Hitachi introduced Southeast Asia’s first proton therapy setup in National Cancer Centre Singapore (NCCS).
It is divided into systems which is further segmented into systems like accelerators which are further divided into cyclotrons, synchrotrons, beam delivery like pencil beam scanning, passive scattering, uniform scanning, modulators and others, along with software, and services.
The components include proton accelerators which is further divided into cyclotrons, synchrotrons, synchrocyclotrons, linacs, H-Minus synchrotrons, separated sector cyclotrons, super-conducting cyclotrons, fast cycling synchrotron beam delivery system like the passive scattering technique and beam scanning, nozzle which is further segmented into pencil scanning nozzle, single scattering, double scattering and uniform scanning nozzle, image viewers, beam transport system and lastly patient positioning system (PPS).
Common proton therapy systems include rotating and non-rotating proton therapy systems.
It is divided into multi-room and single-room systems.
Common application areas include treatment applications like pediatric cancer, tumors in the base of the skull, prostate cancer, head and neck cancer, breast cancer, lung cancer, tumors affecting spine, eye melanoma, lymphoma, pituitary gland tumors, along with research applications.
Major end users include hospitals, ambulatory surgical centers, cancer research institutes and others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Varian Medical Systems, Inc., IBA Group, Hitachi, Ltd., Mevion Medical Systems, Inc., Sumitomo Heavy Industries, Ltd., Optivus Proton Therapy, Inc., ProTom International, Inc., Advanced Oncotherapy Plc., ProNova Solutions, LLC, and Mitsubishi Electric Corporation.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share